Skip to main content

Healhty

4
Pipeline Programs
4
Companies
3
Clinical Trials
2 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
4
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

4 companies ranked by most advanced pipeline stage

Viatris
ViatrisCANONSBURG, PA
1 program
1
Amlodipine and Benazepril HCl Capsules 10 mg/20 mgPhase 11 trial
Active Trials
NCT00649402Completed64Est. Jun 2004
Biocorp
BiocorpFrance - Issoire
1 program
1
BGM1812Phase 1
BrightGene
BrightGeneChina - Suzhou
1 program
1
BGM1812Phase 11 trial
Active Trials
NCT07224399Recruiting60Est. May 2026
WD Pharmaceutical
WD PharmaceuticalChina - Shanghai
1 program
1
Carbidopa and Levodopa Controlled-Release TabletsPhase 11 trial
Active Trials
NCT07442591Recruiting12Est. Dec 2026

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
WD PharmaceuticalCarbidopa and Levodopa Controlled-Release Tablets
BrightGeneBGM1812
ViatrisAmlodipine and Benazepril HCl Capsules 10 mg/20 mg

Clinical Trials (3)

Total enrollment: 136 patients across 3 trials

NCT07442591WD PharmaceuticalCarbidopa and Levodopa Controlled-Release Tablets

A Study to Assess Effect of Dosing Intervals on Multiple-Dose Pharmacokinetics of WD-1603 Taken Before Meals in Healthy Participants

Start: Mar 2026Est. completion: Dec 202612 patients
Phase 1Recruiting
NCT07224399BrightGeneBGM1812

Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of BGM1812 Injection Following Single and Multiple Subcutaneous Administration in Normal to Overweight or Obese But Otherwise Healthy Men and Women

Start: Oct 2025Est. completion: May 202660 patients
Phase 1Recruiting
NCT00649402ViatrisAmlodipine and Benazepril HCl Capsules 10 mg/20 mg

Fed Study of Amlodipine and Benazepril HCl Capsules 10 mg/20 mg to Lotrel® Capsules 10 mg/20 mg

Start: May 2004Est. completion: Jun 200464 patients
Phase 1Completed

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

2 actively recruiting trials targeting 136 patients
4 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.